Evidence‐based treatment of early‐stage melanoma
Identifieur interne : 005316 ( Main/Exploration ); précédent : 005315; suivant : 005317Evidence‐based treatment of early‐stage melanoma
Auteurs : Merrick I. Ross [États-Unis] ; Jeffrey E. Gershenwald [États-Unis]Source :
- Journal of Surgical Oncology [ 0022-4790 ] ; 2011-09-15.
Abstract
The vast majority of patients with newly diagnosed melanoma are “early‐stage” ‐ ie, clinically localized to the primary cutaneous site. For such patients, surgery represents the mainstay of treatment; current standards of surgical management have evolved based on evidence obtained from randomized trials, large multi‐center and single institutional databases, and consensus panels. Treatment strategies include wide excision of the primary site with margins dictated by important biological features such as Breslow tumor thickness, and sentinel node biopsy to surgically evaluate the regional nodal basins at risk. Sentinel node biopsy has become an important component of the initial management of many of these patients for accurate staging of regional lymph nodes, as well as enhanced regional disease control and improved survival in the patients with microscopically involved nodes. Evidence is presented that supports the rational use of these surgical strategies and reconciles some of the controversies that have emerged. The degree to which established national treatment guidelines are followed and the consequences of non‐compliance with these guidelines have become the focus of recent clinical investigations; results of these efforts are also discussed. J. Surg. Oncol. 2011; 104:341–353. © 2011 Wiley‐Liss, Inc.
Url:
DOI: 10.1002/jso.21962
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 004040
- to stream Istex, to step Curation: 004040
- to stream Istex, to step Checkpoint: 000748
- to stream Main, to step Merge: 005355
- to stream Main, to step Curation: 005316
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evidence‐based treatment of early‐stage melanoma</title><author><name sortKey="Ross, Merrick I" sort="Ross, Merrick I" uniqKey="Ross M" first="Merrick I." last="Ross">Merrick I. Ross</name></author><author><name sortKey="Gershenwald, Jeffrey E" sort="Gershenwald, Jeffrey E" uniqKey="Gershenwald J" first="Jeffrey E." last="Gershenwald">Jeffrey E. Gershenwald</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:8860A4048D74B0FEED78A5BB6CE618182A693900</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/jso.21962</idno><idno type="url">https://api.istex.fr/document/8860A4048D74B0FEED78A5BB6CE618182A693900/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">004040</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">004040</idno><idno type="wicri:Area/Istex/Curation">004040</idno><idno type="wicri:Area/Istex/Checkpoint">000748</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000748</idno><idno type="wicri:doubleKey">0022-4790:2011:Ross M:evidence:based:treatment</idno><idno type="wicri:Area/Main/Merge">005355</idno><idno type="wicri:Area/Main/Curation">005316</idno><idno type="wicri:Area/Main/Exploration">005316</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Evidence‐based treatment of early‐stage melanoma</title><author><name sortKey="Ross, Merrick I" sort="Ross, Merrick I" uniqKey="Ross M" first="Merrick I." last="Ross">Merrick I. Ross</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Department of Surgical Oncology (MIR, JEG), The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea></affiliation><affiliation></affiliation></author><author><name sortKey="Gershenwald, Jeffrey E" sort="Gershenwald, Jeffrey E" uniqKey="Gershenwald J" first="Jeffrey E." last="Gershenwald">Jeffrey E. Gershenwald</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Department of Surgical Oncology (MIR, JEG), The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea></affiliation><affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Journal of Surgical Oncology</title><title level="j" type="sub">Seminars in Surgical Oncology: Melanoma</title><title level="j" type="alt">JOURNAL OF SURGICAL ONCOLOGY</title><idno type="ISSN">0022-4790</idno><idno type="eISSN">1096-9098</idno><imprint><biblScope unit="vol">104</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="341">341</biblScope><biblScope unit="page" to="353">353</biblScope><biblScope unit="page-count">13</biblScope><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-09-15">2011-09-15</date></imprint><idno type="ISSN">0022-4790</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0022-4790</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The vast majority of patients with newly diagnosed melanoma are “early‐stage” ‐ ie, clinically localized to the primary cutaneous site. For such patients, surgery represents the mainstay of treatment; current standards of surgical management have evolved based on evidence obtained from randomized trials, large multi‐center and single institutional databases, and consensus panels. Treatment strategies include wide excision of the primary site with margins dictated by important biological features such as Breslow tumor thickness, and sentinel node biopsy to surgically evaluate the regional nodal basins at risk. Sentinel node biopsy has become an important component of the initial management of many of these patients for accurate staging of regional lymph nodes, as well as enhanced regional disease control and improved survival in the patients with microscopically involved nodes. Evidence is presented that supports the rational use of these surgical strategies and reconciles some of the controversies that have emerged. The degree to which established national treatment guidelines are followed and the consequences of non‐compliance with these guidelines have become the focus of recent clinical investigations; results of these efforts are also discussed. J. Surg. Oncol. 2011; 104:341–353. © 2011 Wiley‐Liss, Inc.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Texas</li></region></list><tree><country name="États-Unis"><region name="Texas"><name sortKey="Ross, Merrick I" sort="Ross, Merrick I" uniqKey="Ross M" first="Merrick I." last="Ross">Merrick I. Ross</name></region><name sortKey="Gershenwald, Jeffrey E" sort="Gershenwald, Jeffrey E" uniqKey="Gershenwald J" first="Jeffrey E." last="Gershenwald">Jeffrey E. Gershenwald</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005316 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005316 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:8860A4048D74B0FEED78A5BB6CE618182A693900
|texte= Evidence‐based treatment of early‐stage melanoma
}}
| This area was generated with Dilib version V0.6.31. |  |